Extension Study of MT-1303 in Subjects With Crohn's Disease

An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

NCT01009281 ·Status: TERMINATED ·Phase: PHASE2

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

NCT06450197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

NCT01388933 ·Status: TERMINATED ·Phase: PHASE2

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921 ·Status: COMPLETED ·Phase: PHASE2

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

NCT03467958 ·Status: TERMINATED ·Phase: PHASE3

Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.

NCT06432764 ·Status: COMPLETED ·Phase: PHASE1

Control Crohn Safe Trial

NCT03917303 ·Status: RECRUITING ·Phase: PHASE4

Open-Label Extension Study of GSK1605786A

NCT01318993 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02015793 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

NCT03105102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

NCT02367183 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

NCT03677648 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

NCT04877990 ·Status: COMPLETED ·Phase: PHASE2

B0151005 Open-Label Extension Study

NCT01345318 ·Status: COMPLETED ·Phase: PHASE2

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

NCT00195715 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting

NCT07073079 ·Status: RECRUITING

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

NCT04809363 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Efficacy and Safety of TD-1473 in Crohn's Disease

NCT03635112 ·Status: TERMINATED ·Phase: PHASE2

Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment

NCT02622763 ·Status: TERMINATED ·Phase: PHASE1

Phase 2 Study of the Safety and Efficacy of LDP-02 in Mildly to Moderately Active Crohn's Patients

NCT00655135 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

NCT06023030 ·Status: RECRUITING

Long-term Safety Study of Brodalumab in Adults With Crohn's Disease

NCT01199302 ·Status: TERMINATED ·Phase: PHASE2

Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease

NCT06053424 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

NCT01714726 ·Status: COMPLETED ·Phase: PHASE2

Fecal Transplant for Crohn's Disease

NCT03078803 ·Status: COMPLETED ·Phase: PHASE2